XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
(Accumulated Deficit) Retained Earnings [Member]
Balance at Dec. 31, 2020 $ 1,899,456 $ 880 $ 2,580,327 $ (371,365) $ (310,386)
Balance, shares at Dec. 31, 2020   88,024,000      
Common stock issued under stock incentive plans $ 22,029 $ 10 22,019    
Common stock issued under stock incentive plans, shares 558,322 1,004,000      
Repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises $ (5,734)   (5,734)    
Equity-based compensation expense 37,530   37,530    
Other comprehensive income 371,365     $ 371,365  
Other 2,208   2,208    
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders 190,635       190,635
Balance at Dec. 31, 2021 2,517,489 $ 890 2,636,350   (119,751)
Balance, shares at Dec. 31, 2021   89,028,000      
Common stock issued under stock incentive plans $ 11,613 $ 9 11,604    
Common stock issued under stock incentive plans, shares 285,577 886,000      
Repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises $ (17,792)   (17,792)    
Equity-based compensation expense 29,635   29,635    
Other (1,357)   (1,357)    
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders 273,139       273,139
Balance at Dec. 31, 2022 $ 2,812,727 $ 899 2,658,440   153,388
Balance, shares at Dec. 31, 2022 89,913,659 89,914,000      
Common stock issued under stock incentive plans $ 8,197 $ 14 8,183    
Common stock issued under stock incentive plans, shares 198,527 1,350,000      
Repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises $ (52,532)   (52,532)    
Equity-based compensation expense 32,289   32,289    
Other 2,960   2,960    
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders (21,667)       (21,667)
Balance at Dec. 31, 2023 $ 2,781,974 $ 913 $ 2,649,340   $ 131,721
Balance, shares at Dec. 31, 2023 91,263,989 91,264,000